These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18445995)

  • 1. Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population.
    Sai K; Saito Y; Itoda M; Fukushima-Uesaka H; Nishimaki-Mogami T; Ozawa S; Maekawa K; Kurose K; Kaniwa N; Kawamoto M; Kamatani N; Shirao K; Hamaguchi T; Yamamoto N; Kunitoh H; Ohe Y; Yamada Y; Tamura T; Yoshida T; Minami H; Matsumura Y; Ohtsu A; Saijo N; Sawada J
    Drug Metab Pharmacokinet; 2008; 23(2):139-47. PubMed ID: 18445995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.
    Niemi M; Arnold KA; Backman JT; Pasanen MK; Gödtel-Armbrust U; Wojnowski L; Zanger UM; Neuvonen PJ; Eichelbaum M; Kivistö KT; Lang T
    Pharmacogenet Genomics; 2006 Nov; 16(11):801-8. PubMed ID: 17047488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRP2 haplotypes confer differential susceptibility to toxic liver injury.
    Choi JH; Ahn BM; Yi J; Lee JH; Lee JH; Nam SW; Chon CY; Han KH; Ahn SH; Jang IJ; Cho JY; Suh Y; Cho MO; Lee JE; Kim KH; Lee MG
    Pharmacogenet Genomics; 2007 Jun; 17(6):403-15. PubMed ID: 17502832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of ABCC1 and ABCC2 genotypes and haplotypes in mediating imatinib resistance among chronic myeloid leukaemia patients.
    Au A; Baba AA; Azlan H; Norsa'adah B; Ankathil R
    J Clin Pharm Ther; 2014 Dec; 39(6):685-90. PubMed ID: 25060527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.
    Qu J; Zhou BT; Yin JY; Xu XJ; Zhao YC; Lei GH; Tang Q; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2012 Aug; 18(8):647-51. PubMed ID: 22630058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy.
    Ufer M; von Stülpnagel C; Muhle H; Haenisch S; Remmler C; Majed A; Plischke H; Stephani U; Kluger G; Cascorbi I
    Pharmacogenet Genomics; 2011 Oct; 21(10):624-30. PubMed ID: 21799461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients.
    Ogasawara K; Chitnis SD; Gohh RY; Christians U; Akhlaghi F
    Clin Pharmacokinet; 2013 Sep; 52(9):751-62. PubMed ID: 23633119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.
    Nguyen TD; Markova S; Liu W; Gow JM; Baldwin RM; Habashian M; Relling MV; Ratain MJ; Kroetz DL
    Pharmacogenomics J; 2013 Oct; 13(5):396-402. PubMed ID: 22664480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function.
    Laechelt S; Turrini E; Ruehmkorf A; Siegmund W; Cascorbi I; Haenisch S
    Pharmacogenomics J; 2011 Feb; 11(1):25-34. PubMed ID: 20351751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis.
    Qian L; Fang S; Yan YL; Zeng SS; Xu ZJ; Gong ZC
    J Clin Neurosci; 2017 Mar; 37():6-14. PubMed ID: 27816260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants may play an important role in mRNA-miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379.
    Werk AN; Bruckmueller H; Haenisch S; Cascorbi I
    Pharmacogenet Genomics; 2014 Jun; 24(6):283-91. PubMed ID: 24743544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations and haplotype structures of the ABC transporter gene ABCC1 in a Japanese population.
    Fukushima-Uesaka H; Saito Y; Tohkin M; Maekawa K; Hasegawa R; Kawamoto M; Kamatani N; Suzuki K; Yanagawa T; Kajio H; Kuzuya N; Yasuda K; Sawada J
    Drug Metab Pharmacokinet; 2007 Feb; 22(1):48-60. PubMed ID: 17329911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol.
    Haenisch S; May K; Wegner D; Caliebe A; Cascorbi I; Siegmund W
    Pharmacogenet Genomics; 2008 Apr; 18(4):357-65. PubMed ID: 18334920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between ABCC2 gene variants and treatment response in epilepsy.
    Hilger E; Reinthaler EM; Stogmann E; Hotzy C; Pataraia E; Baumgartner C; Zimprich A; Zimprich F
    Pharmacogenomics; 2012 Jan; 13(2):185-90. PubMed ID: 22256867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variations of the ABCC2 gene in the Chinese, Malay, and Indian populations of Singapore.
    Ho WF; Koo SH; Yee JY; Lee JD
    Drug Metab Pharmacokinet; 2008; 23(5):385-91. PubMed ID: 18974617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than *15.
    Kim SR; Saito Y; Sai K; Kurose K; Maekawa K; Kaniwa N; Ozawa S; Kamatani N; Shirao K; Yamamoto N; Hamaguchi T; Kunitoh H; Ohe Y; Yamada Y; Tamura T; Yoshida T; Minami H; Ohtsu A; Saijo N; Sawada J
    Drug Metab Pharmacokinet; 2007 Dec; 22(6):456-61. PubMed ID: 18159134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs.
    Grover S; Gourie-Devi M; Bala K; Sharma S; Kukreti R
    Pharmacogenet Genomics; 2012 Jun; 22(6):447-65. PubMed ID: 22565165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ATP-binding cassette, sub-family C, number 2 (ABCC2) genotype with pharmacokinetics of irinotecan in Japanese patients with metastatic colorectal cancer treated with irinotecan plus infusional 5-fluorouracil/leucovorin (FOLFIRI).
    Fujita K; Nagashima F; Yamamoto W; Endo H; Sunakawa Y; Yamashita K; Ishida H; Mizuno K; Matsunaga M; Araki K; Tanaka R; Ichikawa W; Miya T; Narabayashi M; Akiyama Y; Kawara K; Ando Y; Sasaki Y
    Biol Pharm Bull; 2008 Nov; 31(11):2137-42. PubMed ID: 18981587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.
    Haenisch S; Zimmermann U; Dazert E; Wruck CJ; Dazert P; Siegmund W; Kroemer HK; Warzok RW; Cascorbi I
    Pharmacogenomics J; 2007 Feb; 7(1):56-65. PubMed ID: 16788565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations and haplotypes of UGT1A4 in a Japanese population.
    Saeki M; Saito Y; Jinno H; Sai K; Hachisuka A; Kaniwa N; Ozawa S; Kawamoto M; Kamatani N; Shirao K; Minami H; Ohtsu A; Yoshida T; Saijo N; Komamura K; Kotake T; Morishita H; Kamakura S; Kitakaze M; Tomoike H; Sawada J
    Drug Metab Pharmacokinet; 2005 Apr; 20(2):144-51. PubMed ID: 15855727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.